SM Magnomint Tablet

SM Magnomint Tablet is a mint-flavoured chewable antacid containing magnesium trisilicate, aluminium hydroxide and dimethicone. The antacid components react with existing stomach acid, while dimethicone has a physical action on gas bubbles. The product is formulated as a chewable tablet for adults and for children over 6 years only at the appropriate reduced dose.

Suitable users depend on age, medical history and the medicines being taken at the same time. Adults may use the product according to the stated dose, while children over 6 years require the reduced dose described in the product information. People with kidney problems, severe abdominal pain or suspected bowel obstruction should seek medical advice before using an antacid containing aluminium and magnesium salts.

Chew the tablet thoroughly before swallowing. The product information states that it may be taken after or between meals and at bedtime, as required. Do not swallow the tablet whole, and follow the stated dose rather than taking additional tablets because symptoms persist.

Adults: 1–2 tablets as required after or between meals and at bedtime, or as directed by a doctor. Children over 6 years: half the adult dose. Children under 6 years: not recommended unless advised by a doctor. The Malaysian product information does not provide a separate maximum daily dose in the cited document; do not exceed the labelled or professionally advised dose.

The shelf life of SM Magnomint Tablet is 3 years when stored as recommended. Do not use the tablets after the expiry date shown on the packaging.

Store below 30°C in an airtight container. Keep the container closed when not in use and protect the tablets from excessive heat and moisture. Always check the expiry date on the packaging before use.

• Common: Mild gastrointestinal changes such as softer stools or constipation may occur with antacid salts.
• Other: Nausea or abdominal discomfort can occur, particularly with excessive use.
• Serious: Seek urgent medical attention for severe abdominal pain, persistent vomiting, signs of an allergic reaction, or marked weakness or confusion.
• Long-term/excessive use: Prolonged or excessive antacid use may disturb mineral or electrolyte balance, particularly in people with kidney impairment.

• Do not use if you have a known hypersensitivity to any ingredient.
• Avoid self-treatment and seek medical assessment if severe abdominal pain or suspected intestinal obstruction is present.
• People with significant kidney impairment should seek medical advice before use because aluminium and magnesium salts may accumulate.

• Antacids can reduce or delay absorption of some oral medicines; separate Magnomint from other medicines by about 2 hours unless a doctor or pharmacist advises otherwise.
• Particular interaction concerns include tetracyclines, some quinolone antibiotics, ketoconazole and certain other medicines whose absorption depends on stomach conditions.
• Tell your pharmacist about all prescription medicines, OTC medicines, vitamins and supplements you take.
• The cited Malaysian product information states drug interactions are not applicable for dimethicone itself; interaction precautions mainly relate to the antacid components.

• Chew the tablet fully before swallowing.
• Keep at least a practical separation from other oral medicines when advised by a pharmacist.
• Do not use repeatedly for persistent or recurrent abdominal symptoms without medical assessment.
• Keep the container tightly closed and store below 30°C.
• Keep out of reach of children.
• Check the label and expiry date before each course of use.

Precautions: Use cautiously if you have kidney impairment, are pregnant or breastfeeding, or take medicines that may have reduced absorption when given with antacids. Persistent or recurrent abdominal symptoms should not be managed repeatedly without professional assessment.

When to See a Doctor or Pharmacist: Seek advice for severe or persistent abdominal pain, repeated vomiting, black or bloody stools, unexplained weight loss, difficulty swallowing, suspected bowel obstruction, or symptoms that continue despite appropriate short-term use.